الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
21 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Asmaa Mohamed Zahran Omar 2024
22 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Samar Abotaleb Mahmou 2024
23 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Dr. Amen Hamdy Zaki Ali 2024
24 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Amany Mohammed Abdel Moatamed 2024
25 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
26 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Shimaa Hassan Shabaan Hassan 2023
27 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Sanaa Saber Abdelraheem Barakat 2023
28 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
29 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
30 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023